Ionic Liquid PCR Inhibitor Suppression for Stool DNA

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Nucleic acid amplification from biological materials is hindered by the presence of inhibitors such as heme, bilirubin, and complex polysaccharides, particularly in stool samples, where existing removal methods are ineffective and can result in loss of target cells or DNA.

Innovation Solution

The use of ionic liquids in the nucleic acid amplification process, which suppresses the activity of nucleic acid amplification inhibitors, thereby improving reaction efficiency and sensitivity by enhancing the polymerase chain reaction (PCR) efficiency and reducing the presence of inhibitors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional removal methods are used to eliminate nucleic acid amplification inhibitors from biological materials, then inhibitor removal is attempted, but target cells or DNA are lost and removal effectiveness is insufficient

Engineering Contradiction:
Improvenucleic acid amplification inhibitor presenceVSAvoidtarget cell or DNA loss
Core Design Contradiction:
Object-affected harmful factorsVSLoss of substance

Solution Approach 1:

Ionic liquids serve as intermediary substances that directly suppress the activity of nucleic acid amplification inhibitors (heme, bilirubin, bile salts, polysaccharides) without requiring complex pre-treatment steps. The ionic liquid molecules interact with the inhibitors to neutralize their harmful effects, allowing PCR to proceed efficiently without losing target cells or DNA.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the chemical environment parameters by introducing ionic liquids with specific properties (charge, polarity, viscosity) into the PCR reaction system. This parameter change allows the reaction to tolerate the presence of inhibitors that would normally prevent amplification, effectively suppressing inhibitor activity without removing the inhibitors themselves.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If pre-treatment methods are used to remove inhibitors before PCR preparation, then inhibitor removal is attempted, but the process becomes complicated and target cells may be lost

Engineering Contradiction:
Improveinhibitor removal effectivenessVSAvoidpre-treatment process complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The ionic liquid is added directly to the PCR master mix before the amplification reaction begins, performing the inhibitor suppression action in advance. This preliminary action eliminates the need for separate, complicated pre-treatment steps while ensuring inhibitors are suppressed before they can interfere with the PCR process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The ionic liquid acts as a mediator substance that bridges the incompatible elements (inhibitors and PCR reaction). By introducing this intermediary, the system can tolerate inhibitor presence without requiring complex separation or removal procedures, significantly simplifying the overall process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of substance

If post-treatment methods are used to add inhibitor removal substances to PCR master mix, then target cell loss is avoided, but inhibitor removal effectiveness remains insufficient

Engineering Contradiction:
Improvetarget cell or DNA preservationVSAvoidinhibitor removal effectiveness
Core Design Contradiction:
Loss of substanceVSObject-affected harmful factors

Solution Approach 1:

The invention uses ionic liquids with specific physicochemical parameters (ionic character, polarity, molecular size) that enable effective inhibitor suppression. By changing the chemical environment through ionic liquid addition, the system achieves superior inhibitor removal effectiveness while maintaining target cell integrity, overcoming the limitations of conventional post-treatment substances.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The PCR master mix is transformed into a composite system by incorporating ionic liquids alongside traditional PCR reagents. This composite formulation combines the functions of DNA polymerase, buffers, dNTPs, primers, and ionic liquids, creating a synergistic system that achieves both target cell preservation and effective inhibitor suppression.

Inventive Principle:
Principle #40Composite materials

4Ease of operation

If conventional PCR is performed in the presence of inhibitors, then the process is simple, but amplification efficiency and sensitivity are reduced

Engineering Contradiction:
ImprovePCR process simplicityVSAvoidamplification efficiency and sensitivity
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

By introducing ionic liquids that change the chemical parameters of the reaction environment (ionic strength, polarity, viscosity), the system maintains operational simplicity while dramatically improving amplification efficiency and sensitivity. The ionic liquid creates an optimized chemical environment that enhances PCR performance without adding operational complexity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively amplifies nucleic acids in the presence of inhibitors, improving PCR efficiency and sensitivity, allowing for rapid and precise detection of target microorganisms or genes without significant loss of target cells or DNA.

Implementation Method 1

amplifying the nucleic acid amplification in the presence of an ionic liquid

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

suppresses the activity of the nucleic acid amplification inhibitor

Methodology Applied
Scientific EffectElectrostatic interactions: Ion Repulsion/Attraction

Data Source

PatentUS9598726B2Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids
Publication Date: 2017.03.21 SAMSUNG ELECTRONICS CO LTD
  • US9598726B2 patent drawing
  • US9598726B2 patent drawing
  • US9598726B2 patent drawing

AI summary

A method for amplifying a nucleic acid amplification in the presence of an ionic liquid that suppresses an inhibitor of nucleic acid amplification, particularly when in a biological material, and a composition useful for performing the method.